A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era.

Scientific Reports
Ryan Mao Heng LimJason Yongsheng Chan

Abstract

Composite follicular lymphoma with diffuse large B-cell lymphoma (FL/DLBCL) is uncommonly found on lymph node biopsy and represents a rare haematological malignancy. We aim to examine clinico-pathological features of patients with FL/DLBCL and investigate predictors of survival outcome. We included in our retrospective study patients with histologically-proven FL/DLBCL at diagnosis (n = 106) and who were subsequently treated with rituximab-based chemoimmunotherapy from 2002-2017 at the National Cancer Centre. The cohort consisted of 34 women and 72 men with a median age of 59 years (range, 24-82). In a multivariate model inclusive of known clinico-pathological parameters at diagnosis, advanced stage (p = 0.0136), presence of MYC and/or BCL6 rearrangement (p = 0.0376) and presence of B symptoms (p = 0.0405) were independently prognostic for worse overall survival (OS). The only remaining independent prognostic variables for worse OS after including first-line treatment data in the model were use of chemotherapy regimens other than R-CHOP (p = 0.0360) and lack of complete response to chemotherapy (p < 0.0001) besides the presence of B symptoms (p = 0.0022). We generated a Clinico-Genotypic Index by point-wise addition of all five...Continue Reading

References

Apr 11, 1974·The New England Journal of Medicine·E S JaffeI Green
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Aug 31, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E GinéA López-Guillermo
May 9, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Silvia MontotoT Andrew Lister
Nov 8, 2007·European Journal of Haematology·Lene Dissing SjöElisabeth Ralfkiaer
Dec 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yasodha NatkunamIzidore S Lossos
Jul 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kai FuJulie M Vose
Oct 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Abdulwahab J Al-TourahJoseph M Connors
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christiane Copie-BergmanThierry J Molina
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharon BarransAndrew Jack
Feb 22, 2012·British Journal of Haematology·Annarita ConconiEmanuele Zucca
Jan 22, 2013·Blood·Heike HornUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group
Jan 7, 2014·Cell Reports·Laura PasqualucciRiccardo Dalla-Favera
Jun 15, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clémentine SarkozyHervé Tilly
May 10, 2017·Expert Review of Hematology·Miriam MendezMariano Provencio
Oct 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L MagnanoA López-Guillermo
Nov 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L MagnanoA López-Guillermo

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

MedCalc

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.